Effectiveness of Prophylactic Coagulation Factor Replacement Therapy in Patients with Severe Hemophilia A in Taiwan – A Population-Based Study

PURPOSE: Taiwan launched reimbursement of prophylactic coagulation factor replacement therapy (CFRT) for patients with severe hemophilia type A (severe PWHA) in 2014. However, since then, the effectiveness of prophylactic CFRT in real-world practice has not been evaluated thoroughly. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Miyuki Hsing-Chun, Chiou, Shyh-Shin, Liao, Tzu-Chi, Lai, Shi-Jie, Lai, Edward Chia-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759011/
https://www.ncbi.nlm.nih.gov/pubmed/36536898
http://dx.doi.org/10.2147/CLEP.S391753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759011/
https://www.ncbi.nlm.nih.gov/pubmed/36536898
http://dx.doi.org/10.2147/CLEP.S391753

Ejemplares similares